Physician compensation is slightly increasing, but Medicare cuts and Advantage plan shifts may impact income and employment models. Nurse practitioners are projected to grow by 40% from 2023 to 2033, ...

So far, organizations are more likely to license general-purpose AI tools than compensation-specific ones to help with pay ...

Forbes contributors publish independent expert analyses and insights. Dr. Shulman provides expertise on entrepreneurial wealth creation. Executive compensation has long been a topic of scrutiny and ...

Jeffrey Johnson has written novels and movies in addition to legal analyses of eminent domain and immigration law. His experience in writing engaging fiction makes him uniquely capable of making the ...

January 07, 2025 - 2024 was a busy year for officials in state regulatory agencies and legislatures as they addressed workers' compensation rates and laws in an effort to reduce costs for employers, ...

Employers expect to increase their compensation budgets by 3.3% for merit increases and 3.7% for total salary increases for non-union workers in 2025, according to a Dec. 10 Mercer report. That ...

As the trend of hospital employment of physicians continues, federal and state governments have increased their focus on physician compensation and compliance with healthcare laws. In the past several ...

The issues addressed below will be explored further at a February 15 event featuring two authors of this Forefront article (Saini and Brownlee) as well as Health Affairs Editor-in-Chief Alan Weil and ...

J.B. Maverick is an active trader, commodity futures broker, and stock market analyst 17+ years of experience, in addition to 10+ years of experience as a finance writer and book editor. Anthony ...

Imagine serving years, even decades in prison for a crime you didn't commit and then - when you're finally exonerated and released - you're not guaranteed any form of compensation under the law. In at ...

The Covid-19 pandemic has triggered a global vaccine race. As of September 27, 2020, there were more than 200 vaccine candidates in preclinical and clinical development, including 11 in phase 3 trials ...